Please login to the form below

Not currently logged in
Email:
Password:

Imfinzi

This page shows the latest Imfinzi news and features for those working in and with pharma, biotech and healthcare.

Imfinzi aces survival challenge in lung cancer

Imfinzi aces survival challenge in lung cancer

Imfinzi aces survival challenge in lung cancer. Earlier treatment leads to much extended lives, data suggests. ... Imfinzi plus experimental CTLA4 inhibitor tremelimumab failed to show improved PFS compared to chemotherapy.

Latest news

More from news
Approximately 12 fully matching, plus 41 partially matching documents found.

Latest Intelligence

  • China: AstraZeneca’s new engine for growth and innovation China: AstraZeneca’s new engine for growth and innovation

    Its Imfinzi has secured the first-ever US and EU approval in locally- advanced, unresectable non-small cell lung cancer – a potentially game-changing early use which could have enormous potential

  • Cancer immunotherapy: What's on the horizon? Cancer immunotherapy: What's on the horizon?

    And AZ’s Imfinzi (durvalumab) meanwhile has shown its worth as a maintenance therapy to stop recurrence of earlier-stage, locally-advanced NSCLC. ... For instance, AZ’s MYSTIC of Imfinzi and CTLA4 drug tremelimumab in lung cancer wasn’t able to

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Four Health Communications

Formerly known as Packer Forbes Communications, Four Health Communications is an award-winning, integrated healthcare communications agency for pharma, biotech, NGOs...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe’s leading hub for life sciences innovation...

Infographics